The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

A rare liver disorder in a newborn became the testbed for the first in vivo CRISPR therapy, led by Berkeley’s Innovative ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

UCD team uses novel polymer-based system to deliver corrective genes, an approach that appears to be better tolerated by ...

The global biotechnology market is anticipated to surge to USD 1.78 trillion by 2034, driven by innovations in personalized ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

PR Newswire SAN FRANCISCO, July 8, 2025 SAN FRANCISCO, July 8, 2025 /PRNewswire/ -- Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to ...

India offers a treasure trove of genetic data for AI-enabled researchers to develop therapies neglected by commercial ...

In vivo base editing enables precise, single-nucleotide changes to DNA without double-strand breaks. A recent application in ...

R are genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend ...

Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...